Skip Navigation

JNCI Journal of the National Cancer Institute 1998 90(2):94-96; doi:10.1093/jnci/90.2.94
© 1998 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McCann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCann, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

PET Scans Approved for Detecting Metastatic Non-Small-Cell Lung Cancer

For years, dedicated positron emission tomography scanners have been used in Europe to diagnose the status of lesions too small to biopsy or to find those too small to be detected by a computerized tomography scanner.

Now, for the first time in the United States, the Health Care Financing Administration has authorized Medicare to pay for the use of PET for the detection of metastatic disease in non-small-cell lung cancer patients who are newly diagnosed. Such imaging may be able to help physicians decide whether or not curative surgery is feasible. HCFA officials have said they will "periodically review" the approval both for PET and for . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?